Mohamed Rashad has spent more than a decade on both sides of pharmaceutical regulation, preparing and managing regulatory dossiers within the pharmaceutical industry, and assessing them as a regulator.

He currently serves as Manager of the Evaluation Unit for Re-Registration Files – Local Human Pharmaceuticals at the Egyptian Drug Authority (EDA), where his work focuses on the technical evaluation of re-registration and lifecycle submissions for human pharmaceutical products. Earlier in his career, he held regulatory leadership roles at CADC and within the pharmaceutical industry.

His expertise spans CMC, CTD and eCTD dossiers, variations and lifecycle management, regulatory strategy, and pharmaceutical submissions across Egypt, the MENA region, and African markets.

He holds a BSc in Pharmaceutical Sciences, a Diploma in Pharmaceutical Quality Control and an MBA.